1. Home
  2. SPRC vs XRTX Comparison

SPRC vs XRTX Comparison

Compare SPRC & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • XRTX
  • Stock Information
  • Founded
  • SPRC 2004
  • XRTX 2011
  • Country
  • SPRC Israel
  • XRTX Canada
  • Employees
  • SPRC N/A
  • XRTX N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • XRTX Pharmaceuticals and Biotechnology
  • Sector
  • SPRC Health Care
  • XRTX Health Care
  • Exchange
  • SPRC Nasdaq
  • XRTX Nasdaq
  • Market Cap
  • SPRC 3.0M
  • XRTX 3.4M
  • IPO Year
  • SPRC N/A
  • XRTX N/A
  • Fundamental
  • Price
  • SPRC $5.16
  • XRTX $0.90
  • Analyst Decision
  • SPRC
  • XRTX
  • Analyst Count
  • SPRC 0
  • XRTX 0
  • Target Price
  • SPRC N/A
  • XRTX N/A
  • AVG Volume (30 Days)
  • SPRC 41.7K
  • XRTX 88.1K
  • Earning Date
  • SPRC 02-15-2025
  • XRTX 08-18-2025
  • Dividend Yield
  • SPRC N/A
  • XRTX N/A
  • EPS Growth
  • SPRC N/A
  • XRTX N/A
  • EPS
  • SPRC N/A
  • XRTX N/A
  • Revenue
  • SPRC $1,306,000.00
  • XRTX N/A
  • Revenue This Year
  • SPRC N/A
  • XRTX N/A
  • Revenue Next Year
  • SPRC N/A
  • XRTX N/A
  • P/E Ratio
  • SPRC N/A
  • XRTX N/A
  • Revenue Growth
  • SPRC N/A
  • XRTX N/A
  • 52 Week Low
  • SPRC $4.14
  • XRTX $0.66
  • 52 Week High
  • SPRC $37.59
  • XRTX $2.98
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 33.07
  • XRTX 58.25
  • Support Level
  • SPRC $5.05
  • XRTX $0.73
  • Resistance Level
  • SPRC $5.59
  • XRTX $0.91
  • Average True Range (ATR)
  • SPRC 0.44
  • XRTX 0.06
  • MACD
  • SPRC -0.17
  • XRTX 0.02
  • Stochastic Oscillator
  • SPRC 3.41
  • XRTX 96.05

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: